Women in Advanced Therapies Congress logo

Redefining inclusion in CGT

The Women in Advanced Therapies (WIAT) Congress at Advanced Therapies Week 2027 is a dedicated forum for building inclusive leadership, advancing mentorship, and closing gaps in research, investment, and healthcare. Through open dialogue and inspiring role models, WIAT empowers leaders, early-career professionals, and allies to drive diversity and shape the future of cell and gene therapy.

Add this Congress to your ticket

*Add the WIAT Congress to your Advanced Therapies Week ticket for $99 at checkout.

What to expect on the day

Hosted on Day 1 of Advanced Therapies Week, Monday, January 18, the WIAT Congress provides a dedicated forum for reflection, dialogue, and empowerment. Whether you’re an established leader, an early-career professional, or an ally, you’ll leave with new perspectives, and expanded networks.

Roundtable discussions

Collaborate in peer-led sessions tackling topics such as inclusive leadership, mentorship, and overcoming investment barriers.

Inspiring role models

Learn from women shaping the future of advanced therapies, from pioneering scientists to industry trailblazers and policy advocates.

Scientific deep-dives

Unpack the clinical and translational relevance of sex differences in cell and gene therapy research.

Allyship in action

Discover tangible strategies for fostering inclusive workplaces, supporting diverse teams, and lifting up the next generation of talent.

Want a preview of the Advanced Therapies Week attendees?

See who was in the room in 2026 and the organizations leading the way in advanced therapies.

Download the 2026 attendee list

  • “Advanced Therapies Week is one of the best partnering conferences around… they really focus on connections.”
    Global Commercial Director, ScaleReady
  • “Why ATW is fantastic is all the tech developers and manufacturers are here in one place with one idea in mind, and that is to advance the field.”
    VP, Cellular Origins
  • “It’s a great opportunity for us to connect with all different people — whether they come from small biotech, big pharma, or academia. It gives us insight into CGT trends and how to adjust our workflows to meet the market.”
    Clinical Product Manager, Miltenyi Biotech
  • “This is one of the landmark meetings. Every year it becomes obvious that we meet more of our potential partners, we can build together the future of cell therapy and see how we can implement this concretely.”
    CEO & Founder, NKILT Therapeutics